Opinion|Videos|September 6, 2024
Optimizing Pneumococcal Vaccination Efforts in High-Risk Patients
The key opinion leaders explore effective methods for educating patients about pneumococcal vaccination, highlighting its importance and benefits, while also addressing the impact of COVID-19 on vaccine hesitancy and potential fatigue in the general population.
Advertisement
Episodes in this series
- What How can we engage with patients to educate and emphasize the need and benefits associated with immunizing against pneumococcal disease?
- The COVID-19 pandemic has created a significant amount of vaccine fatigue and hesitancy. How do you identify these in your practice and how can they be overcome to achieve optimal vaccination rates?
- What impact do social determinants such as racial and ethnic disparities have on the vaccination rates of pneumococcal vaccines in underserved populations (health equity vs. equality)?
- What are the cost barriers that are present with pneumococcal vaccination and how can they be overcome?
- What does good collaboration look like between stakeholders in an effort to vaccinate in underserved populations?
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Ban Synthetic 7-OH: Natural Leaf Kratom Presents No Major Health Risk
2
Is Berberine Nature’s GLP-1?
3
Glucodensity Analysis Enhances CGM Accuracy for Detecting Cystic Fibrosis–Related Diabetes
4
Incidence of Invasive Fungal Infections Following BCMA-Directed CAR T-Cell Therapy in Multiple Myeloma
5
